RESOURCES

Glu is an online community of patients and caregivers who support, empower, and educate one another while participating directly in real-time research.
T1D Exchange Clinic Network supports a large registry of adults and children with T1D for the purpose of conducting multiple studies proposed by T1D Exchange investigators, other researchers, and corporate members.
T1D Exchange Clinic Registry supports research and development projects and programs in T1D by helping researchers characterize individuals living with the disease, conduct exploratory or hypothesis-generating analyses, and identify participants for future clinical studies.
T1D Exchange Biobank centralizes thousands of biological samples—together with clinical, demographic, and study-derived information—and aims to be a world-class resource for innovative research, a catalyst for exchange of knowledge and collaboration, and addresses the unmet need of having biological samples to better understand the causes of T1D, the heterogeneity in clinical course over time, and responses to therapy.

RESEARCH + STUDIES

Beyond Type 1 Diabetes: When T1D Isn’t the Only Uninvited House Guest

A T1D Exchange study analyzes the frequency of autoimmune disorders and T1D Are you living with type 1 diabetes and another autoimmune condition? You are not alone. A recent T1D Exchange study reveals that people [...]

Why Do Some People with T1D Stop Using a Pump and CGM?

T1D Exchange researched factors associated with discontinuation of pump and CGM Data show that the use of an insulin pump and/or continuous glucose monitors (CGM) improve glycemic control. Yet, only a small percentage of people [...]

Six-Month Clinical Trial Reveals Addition of Metformin Fails to Improve Glycemic Control in Adolescents Living with Type 1 Diabetes

Showed improvements to cardiovascular risks—reduced weight, BMI, total daily insulin usage BOSTON, December 1, 2015––Six months of adjunctive metformin therapy does not improve glycemic outcomes in obese adolescents with type 1 diabetes, according to new [...]

NEWS

T1D Exchange and M2D2 Announce the Winners of the First Annual Diabetes Innovation Challenge

Integrated Medical and Enable Biosciences selected as the co-winners of the first open, global competition to accelerate products and solutions to improve the lives of those living with type 1 and type 2 diabetes Boston, [...]

Transformational Competitors Advance to the Finals of the Inaugural Diabetes Innovation Challenge

Finalists to present innovative advancements in diabetes diagnostics, therapeutics, devices, or solutions that aim to improve patient outcomes for those living with type 1 and type 2 diabetes Boston, MA – October 13, 2016 – [...]

T1D Exchange Initiates Multimillion Dollar Investment in Automated Insulin Delivery Technologies

Ambitious Initiative Aimed to Speed the Development and Delivery of Safe, Effective Solutions for Those Living with Type 1 Diabetes Boston, MA – October 5, 2016 – T1D Exchange, a nonprofit organization driving faster, better [...]

MEMBERS